These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 33466167)
21. Comprehensive analyses of a CD8 Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525 [TBL] [Abstract][Full Text] [Related]
22. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Li Y; Zheng P; Zhan X Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015 [TBL] [Abstract][Full Text] [Related]
23. Development of a disulfidptosis-related lncRNA prognostic signature for enhanced prognostic assessment and therapeutic strategies in lung squamous cell carcinoma. Zhu A; Zong Y; Gao X Sci Rep; 2024 Aug; 14(1):17804. PubMed ID: 39090162 [TBL] [Abstract][Full Text] [Related]
24. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma. Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090 [TBL] [Abstract][Full Text] [Related]
25. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719 [TBL] [Abstract][Full Text] [Related]
26. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer. Tian WJ; Liu SS; Li BR Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552 [TBL] [Abstract][Full Text] [Related]
27. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma. Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ Front Oncol; 2020; 10():1588. PubMed ID: 33014809 [TBL] [Abstract][Full Text] [Related]
28. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma. Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177 [TBL] [Abstract][Full Text] [Related]
29. Identification of RNMT as an immunotherapeutic and prognostic biomarker: From pan-cancer analysis to lung squamous cell carcinoma validation. Huang S; Tan C; Zheng J; Huang Z; Li Z; Lv Z; Chen W; Chen M; Yuan X; Chen C; Yan Q Immunobiology; 2024 Sep; 229(5):152836. PubMed ID: 39018675 [TBL] [Abstract][Full Text] [Related]
30. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network. Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871 [TBL] [Abstract][Full Text] [Related]
31. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients. Wang K; Li Y; Wang J; Chen R; Li J Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782 [TBL] [Abstract][Full Text] [Related]
32. Plasma extracellular vesicle long RNA profiling identifies a predictive signature for immunochemotherapy efficacy in lung squamous cell carcinoma. Zhang X; Liao J; Yang W; Li Q; Wang Z; Yu H; Wu X; Wang H; Sun S; Zhao X; Hu Z; Wang J Front Immunol; 2024; 15():1421604. PubMed ID: 39161762 [TBL] [Abstract][Full Text] [Related]
33. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma. Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578 [TBL] [Abstract][Full Text] [Related]
34. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients. Zhang T; Yang H; Sun B; Yao F Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598 [TBL] [Abstract][Full Text] [Related]
35. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412 [TBL] [Abstract][Full Text] [Related]
36. Identification of a glycolysis-related gene signature associated with clinical outcome for patients with lung squamous cell carcinoma. Xu Z; Zhang S; Nian F; Xu S Cancer Med; 2021 Jun; 10(12):4017-4029. PubMed ID: 33991070 [TBL] [Abstract][Full Text] [Related]
37. Establishment of the prognostic index of lung squamous cell carcinoma based on immunogenomic landscape analysis. Zhang J; Zhang J; Yuan C; Luo Y; Li Y; Dai P; Sun W; Zhang N; Ren J; Zhang J; Gong Y; Xie C Cancer Cell Int; 2020; 20():330. PubMed ID: 32699529 [TBL] [Abstract][Full Text] [Related]
38. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma. Zhou W; Zhang W BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504 [TBL] [Abstract][Full Text] [Related]
39. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles. Wang W; Wang S; Chu X; Liu H; Xiang M J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242 [TBL] [Abstract][Full Text] [Related]
40. Identification of an Individualized Immune-Related Prognostic Risk Score in Lung Squamous Cell Cancer. Zhuang Y; Li S; Liu C; Li G Front Oncol; 2021; 11():546455. PubMed ID: 33747902 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]